Glen Eagle Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$268K Sell
3,882
-619
-14% -$42.7K 0.04% 223
2025
Q1
$305K Sell
4,501
-522
-10% -$35.4K 0.05% 201
2024
Q4
$225K Sell
5,023
-2,667
-35% -$120K 0.04% 225
2024
Q3
$484K Sell
7,690
-1,507
-16% -$94.8K 0.08% 148
2024
Q2
$543K Sell
9,197
-664
-7% -$39.2K 0.1% 133
2024
Q1
$786K Sell
9,861
-161
-2% -$12.8K 0.15% 110
2023
Q4
$791K Sell
10,022
-558
-5% -$44.1K 0.16% 108
2023
Q3
$739K Sell
10,580
-585
-5% -$40.8K 0.17% 105
2023
Q2
$772K Sell
11,165
-110
-1% -$7.6K 0.18% 101
2023
Q1
$838K Buy
11,275
+4
+0% +$297 0.21% 93
2022
Q4
$1.05M Sell
11,271
-51
-0.5% -$4.75K 0.29% 73
2022
Q3
$1.08M Sell
11,322
-11
-0.1% -$1.05K 0.31% 67
2022
Q2
$1.05M Sell
11,333
-78
-0.7% -$7.23K 0.28% 72
2022
Q1
$1.15M Buy
11,411
+65
+0.6% +$6.58K 0.3% 71
2021
Q4
$1.17M Sell
11,346
-409
-3% -$42.2K 0.3% 75
2021
Q3
$998K Buy
11,755
+136
+1% +$11.5K 0.29% 73
2021
Q2
$969K Buy
11,619
+486
+4% +$40.6K 0.3% 71
2021
Q1
$838K Buy
11,133
+999
+10% +$75.2K 0.29% 76
2020
Q4
$692K Sell
10,134
-433
-4% -$29.6K 0.27% 76
2020
Q3
$617K Buy
10,567
+985
+10% +$57.5K 0.28% 78
2020
Q2
$623K Buy
9,582
+3,698
+63% +$240K 0.32% 72
2020
Q1
$349K Buy
5,884
+1,025
+21% +$60.8K 0.24% 97
2019
Q4
$361K Buy
4,859
+234
+5% +$17.4K 0.19% 108
2019
Q3
$292K Buy
4,625
+801
+21% +$50.5K 0.19% 108
2019
Q2
$208K Buy
3,824
+427
+13% +$23.3K 0.14% 139
2019
Q1
$183K Buy
3,397
+18
+0.5% +$971 0.13% 147
2018
Q4
$221K Buy
3,379
+127
+4% +$8.32K 0.19% 115
2018
Q3
$256K Sell
3,252
-260
-7% -$20.5K 0.18% 119
2018
Q2
$226K Sell
3,512
-90
-2% -$5.79K 0.18% 127
2018
Q1
$224K Buy
3,602
+80
+2% +$4.98K 0.18% 120
2017
Q4
$255K Sell
3,522
-357
-9% -$25.9K 0.22% 105
2017
Q3
$315K Sell
3,879
-3,167
-45% -$258K 0.29% 81
2017
Q2
$567K Buy
7,046
+411
+6% +$33.1K 0.45% 54
2017
Q1
$523K Hold
6,635
0.45% 58
2016
Q4
$524K Buy
+6,635
New +$524K 0.47% 62